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OBJECTIVES: To examine primary care physician (PCP)
contributions toward racial and sex differences in the di-
agnosis and treatment of late-life depression.
DESIGN: Survey using a computerized instrument incor-
porating video interviews and text, with volunteer PCPs
randomly assigned to one of four standardized video vi-
gnettes of an elderly patient depicting late-life depression.
Vignettes differed only in the patient/actor’s race (white/
African-American) or sex.
SETTING: American Academy of Family Physicians meet-
ing, San Diego, California, 2002.
PARTICIPANTS: One hundred seventy-eight U.S.-practic-
ing postresidency PCPs who were asked to participate in a
clinical decision-making study.
MEASUREMENTS: The computerized survey instrument
assessed PCPs’ diagnoses, first-line treatment and manage-
ment recommendations, and judgment of personal charac-
teristics/behaviors for the patients in the vignettes.
RESULTS: Eighty-five percent of all PCPs correctly diag-
nosed the elderly patient(s) with major depression. There
were no significant differences in the diagnosis of depres-
sion, treatment recommendations, or PCP assessment of
most patient characteristics by the race or sex of the patient/
actor in the vignette, but PCP characteristics, most notably
the location of medical school training (U.S. vs interna-
tional), affected the likelihood of a depression diagnosis and
treatment recommendations.
CONCLUSION: Given standardized symptom-pictures,
PCPs are just as likely to diagnose and treat depression in
African-American as in white older people, suggesting that
bias based simply on apparent patient race is not a likely
explanation for the lower rates of depression diagnosis and
treatment in older African Americans. PCPs who have
trained at international medical schools may benefit from
targeted training initiatives on the diagnosis and treatment
of late-life depression. J Am Geriatr Soc 53:777–784, 2005.
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Major depression causes significant morbidity and maycontribute to mortality in late life,1 but studies in-
dicate that late-life depression continues to be underdiag-
nosed and undertreated.2–4 Few older adults with
depression receive mental health services; instead they are
usually treated in primary care settings. Medical and neu-
ropsychiatric comorbidities complicate accurate diagnosis
and treatment of late-life depression.5 Such factors as the
patient’s race or sex may also affect diagnosis and treatment
decisions. Many studies report lower rates of depression
diagnoses (and higher rates of psychotic diagnoses) in Af-
rican Americans than in whites in psychiatric settings.6–10
The few studies that have examined racial differences in
diagnostic rates in older adults report similar results.11–14
Older African Americans in the community may also be less
likely to use antidepressants than older white people.15
Fewer studies have examined racial and sex variation in
depression treatment in primary care. Elderly patients, men,
and African Americans are more likely to see primary care
physicians (PCPs) than psychiatrists for mental health
treatment.16 As a result, it is particularly important to as-
sess potential disparities in the diagnosis and treatment of
depression in primary care settings. One study found that
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PCPs were less likely to counsel African-American than
white patients for depression,17 although this difference re-
solved after adjusting for patients’ education level and so-
cioeconomic status (SES). Another study found that African
Americans were less likely than whites to find antidepres-
sant medication acceptable.18 In primary care settings, old-
er women have higher rates of depression diagnosis and
treatment than older men,19 but a recent study found that
neither depression diagnosis nor antidepressant treatment
recommendations by PCPs were associated with patient
age, race, sex, or SES.20
Although differences in rates of clinical diagnosis and
treatment of depression by race have been frequently found
in mixed-age and elderly samples, few studies have evalu-
ated why these differences are found. Differences in rates of
diagnosis and treatment may reflect a multitude of factors,
but misdiagnosis and clinician bias are the most frequently
cited possible etiological factors,8–10,21–24 although the ev-
idence is limited25 and often indirect.23,24
Although it is hazardous to infer bias solely from the
existence of health disparities,25 this inference has been
made repeatedly, largely based upon the cross-classification
of race and the diagnosis of psychotic/mood disorders.26
Racial bias involves making unwarranted judgments about
people on the basis of their race.25 Although race is most
simply associated with an individual’s skin color and phys-
ical characteristics, it may also act as a proxy for culturally
mediated beliefs, values, and communication styles as well
as become confounded with the effects of SES. In the ex-
treme, clinician bias assumes that, given the same set of
symptoms, clinicians unconsciously assign a certain diag-
nosis based upon a patient’s skin color and associated
physical characteristics (e.g., assigning an African-Ameri-
can patient a psychotic disorder diagnosis and a white pa-
tient an affective disorder diagnosis).
The potential effect of racially based bias on the diag-
nosis and treatment of depression may be even more critical
in the elderly, in whom depression management is already
complex because of medical illness and neuropsychiatric
comorbidity. Potential mismanagement of a mood disorder
as a psychotic disorder in an elderly minority patient could
lead to poor outcomes and side effects such as tardive
dyskinesia. Tardive dyskinesia is more common in African-
American patients27 and could be a direct consequence of
the misdiagnosis and management of a mood disorder as a
psychotic disorder. Evaluating whether PCPs contribute to
mental health disparities may inform efforts to improve the
diagnosis and treatment of late-life depression in specific
patient subgroups.
The Surgeon General’s report on mental health dispar-
ities28 notes that the role of clinician bias in racial differ-
ences in the diagnosis of mental disorders remains a
complex issue demanding a series of innovative research
studies. As a first step toward investigating the role of phy-
sician bias in racial disparities in the diagnosis and treat-
ment of late-life depression in primary care settings, a
controlled experiment was conducted that standardized
patient presentation and symptom report. It was hy-
pothesized that patient race (as indicated to partici-
pants by skin color, facial features, and speech style) and




Similar to a previous study examining the effects of race and
sex on treatment recommendations in cardiology,29 a com-
puterized survey instrument was developed that incorpo-
rated video recorded interviews of elderly patients with
symptoms of major depression. The computerized survey
was designed to record PCPs’ demographic characteristics,
assess PCPs’ diagnosis and management recommendations
for the patients in the vignettes, and examine PCPs’ judg-
ment of patient characteristics.
The 5-minute video consisted of a scripted interview
with a patient/actor. Four board-certified geriatric psychi-
atrists (HCK, AMM, SMM, BAK) wrote and reviewed the
script for major depression. Established Diagnostic and
Statistical Manual of Mental Disorders, Fourth Edition
(DSM-IV) criteria for major depression30 were met, but the
script was also created with the frequent medical and neu-
ropsychiatric complexity of late-life depression in mind.5
The effect of race on interpretations of behavior also may be
exacerbated when behavior is ambiguous or open to mul-
tiple interpretations.31 Therefore, the script included the
ambiguity often present in clinical situations, with other
symptoms such as cognitive problems, alcohol use, and
paranoia accompanying symptoms of depression. The writ-
ten vignette was piloted individually with two board-cer-
tified psychiatrists (blind to the purpose of the study), both
of whom diagnosed the patient with major depression.
To represent the possible combinations of race and sex,
four actors were recruited to portray the patients in the
vignettes (Figure 1). As in the Schulman et al. study, actors
were used because they were considered better able than
patients to read the scripts verbatim and to express con-
sistent affect across vignettes. Vignettes were recorded at a
single studio (Russell Video Services, Ann Arbor, MI) and
produced by ImageWeaver Studios (Ann Arbor, MI), a
company with expertise in educational medical video pro-
duction. Actors followed identical scripts and direction,
dressed in similar clothing, and displayed the same affect
within video segments. The four video vignettes (white fe-
male (WF), white male (WM), African-American female
Figure 1. Patients as portrayed by actors in the video portion of
survey.
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(AF), and African-American male (AM)) were each piloted
separately with at least two additional board-certified psy-
chiatrists (12 psychiatrists in total) who were blind to the
purpose of the study. The rate of agreement on diagnosis
across all observers was 93%.
A computer screen that listed the patient’s age (73),
medical conditions (diabetes mellitus, arthritis, and hyper-
tension), insurance status (Medicare and Blue Cross Blue
Shield supplemental insurance), and information that his or
her daughter brought the patient in introduced the video
patient interview segment. To assess decisions about diag-
nosis, PCPs were asked to choose the single-best DSM-IV
diagnosis for the patient based on the information from the
video. Choices included major depression, dementia, delu-
sional disorder, schizophrenia, and alcohol abuse. They
were then asked their degree of certainty in their primary
diagnosis. PCPs were also presented with a list of possible
treatment choices and asked to select their preferred initial
treatment for the patient. They were surveyed about how
long they would follow the patient, when they would con-
sider referring the patient to a psychiatrist, and the one
piece of additional information (e.g., head computed tomo-
graphy scan, medical history, Mini-Mental State Examina-
tion (MMSE) score, substance history) they would want to
make a more certain diagnosis and formulate treatment
recommendations.
The final portion of the survey involved PCPs’ judg-
ment about patient characteristics (modified from the
Schulman et al. survey; Schulman KA, personal communi-
cation). Patient characteristics included patient attributes
(demeanor toward the examiner and SES) and predicted
behaviors (complying with and benefiting from treatment,
forming an alliance with the physician, understanding rec-
ommendations, and likelihood of experiencing side effects).
Viewing the vignette and answering the survey took
approximately 10 minutes. The software program required
viewing the entire vignette before answering survey ques-
tions and presentation of all components of the survey in-
strument before completion.
Study Subjects and Data Collection
PCP subjects were participants at the 2002 American Acad-
emy of Family Physicians Annual Meeting in San Diego,
California. PCPs were recruited on site; those completing
the study received a calculator as remuneration. PCP par-
ticipants were told that they were taking part in a study of
clinical decision-making involving mental health issues in
primary care, but they were not told that the primary pur-
pose of the study was to assess the effect of race and sex on
the diagnosis and treatment of late-life depression.
Surveys were administered in a main meeting exhibit
hall booth that had six individual computer stations. The
layout was designed to provide the participants privacy and
prevent them from viewing each other’s video interviews/
surveys. The PCPs were randomly assigned to view one of
the four vignettes.
Sample Size
Based upon prior differences found for rates of clinical de-
pression diagnoses in older people by race (19% diagnosed
mood disorders in whites and 8% in African Americans),14
the required sample size was estimated based on an ability
to detect a medium effect size.32 Using an alpha level of
0.05, 40 participants per group ensured a power of 97% to
detect main effects for race group and sex group.
Statistical Analysis
PCPs’ diagnostic assessments, management recommenda-
tions, and judgments of patient characteristics based on the
randomly assigned video vignettes were examined using the
following analyses. First, univariate (mean, standard devi-
ation) and bivariate (Spearman and Pearson correlations)
descriptive statistics were calculated overall and by vi-
gnette. Chi-square (w2) tests were used to examine differ-
ences in categorical variables. One-way analysis of variance
was used to examine group differences in continuous out-
come measures. Tukey’s Honestly Significant Differences
procedure for correction of multiple comparisons was used
to test post hoc differences between vignettes. For all anal-
yses, alpha was set at 0.05, and all tests were two-sided.
Logistic regression analyses were conducted to assess
the effects of PCP characteristics on diagnosis and treat-
ment recommendations, controlling for patient race and
sex. PCP characteristics used as predictors were age, sex,
race, medical school location (U.S. vs international), prac-
tice location, board certification, and years since gradua-
tion. Physician race was dichotomized as white versus
nonwhite rather than using several racial categories because
of the small numbers (6.2%) of African-American PCPs.
Separate logistic regression models were estimated for each
PCP characteristic because of the high multicollinearity
between the predictors.
RESULTS
One hundred seventy-eight PCPs volunteered to participate
in the study. These subjects were randomly assigned to each
patient vignette and did not differ significantly on any PCP
characteristics (Table 1).
Primary Diagnosis
Eighty-five percent (n 5 151) of PCPs diagnosed the elderly
patient as having major depression as the primary diagnosis.
Analysis of provider diagnosis by vignette viewed showed
the following percentages of a diagnosis of major depression:
WF 5 79.6% (n 5 35), WM 5 80.4% (n 5 37), AF 5 87.0%
(n 5 40), and AM 5 92.9% (n 5 39) (w2 5 3.91, degrees of
freedom (df) 5 3, P 5.27). The other psychiatric diagnoses
chosen by PCPs included dementia, delusional disorder, and
schizophrenia. Follow-up comparisons indicated that the
AM was no more likely to receive a diagnosis of depression
than the WF, WM, or AF (95% confidence interval
(CI) 5 0.08–1.19, 0.08–1.26, and 0.12–2.20, respectively).
Level of Certainty in Diagnosis
Of PCPs choosing a diagnosis of major depression
(n 5 151), there were significant differences in mean level
of certainty (rated as 0–100%) in this diagnosis by vignette
viewed (WF 5 71.0%, WM 5 66.9%, AF 5 80.4%, AM 5
72.2%; F 5 4.15, df 5 3,147, Po.001). Post hoc analyses
revealed that the mean level of certainty rated by PCPs for
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the AF was significantly higher than that rated for the WM
(Po.05).
Management Recommendations
PCPs did not differ in their treatment recommendations for
the patient viewed. The majority of PCPs chose an antide-
pressant as their first-line treatment. By vignette viewed, the
percentage of PCPs choosing any antidepressant was
WF 5 81.8% (n 5 36), WM 5 89.1% (n 5 41), AF 5 89.1%
(n 5 41), and AM 5 90.5% (n 5 38) (w2 5 1.88, df 5 3,
P 5.60). Most PCPs chose newer antidepressant agents
(e.g., selective serotonin reuptake inhibitors) as their first-line
treatment; by vignette viewed, the percentage of PCPs choos-
ing newer antidepressants was WF 5 77.3% (n 5 34),
WM 5 89.1% (n 5 41), AF 5 87.0% (n 5 40), and AM 5
85.7% (n 5 36) (w2 5 2.80, df 5 3, P 5.42).
Across vignettes, the top three follow-up choices were
follow up for more than 6 months, follow up for 1 to 3
months, and referral to a non-medical doctor mental health
provider (e.g., psychologist, social worker) (Table 2). Col-
lapsing the follow-up choices into follow-up for more than
6 months versus other, it was found that there were no
significant differences by vignette viewed as indicated by
PCPs (w2 5 5.14, df 5 3, P 5.16).
PCPs’ choices regarding potential psychiatric referral
also did not differ by vignette viewed. Across vignettes, the
most common response, given by 57.3% (n 5 102) of the
PCPs, was that they would refer the patient to a psychiatrist
‘‘if there was a poor treatment response after 1 to 3
months,’’ followed by 24.2% (n 5 43) referring for poor
response after 4 to 6 months, and 8.4% (n 5 15) referring
for a poor response after more than 6 months. Approxi-
mately 5.6% (n 5 10) of the PCPs responded that they
would refer immediately after the evaluation, and 4.5%
(n 5 8) responded that they would never refer.
PCPs also indicated that the single piece of additional
information they would most like regarding the patient
was a full medical history and laboratory test infor-
mation (WF 5 40.9% (n 5 18), WM 5 39.1% (n 5 18),
AF 5 52.2% (n 5 24), AM 5 57.1% (n 5 24)), followed
by MMSE (WF 5 47.7% (n 5 21), WM 5 52.2% (n 5 24),
AF 5 43.5% (n 5 20), AM 5 31.0% (n 5 13)). Other addi-
tional information chosen by PCPs included full substance
abuse history and head computed tomography. Collapsing
the choices into full medical history and laboratory work
versus other, the PCPs did not differ significantly by vignette
viewed (w2 5 4.02, df 5 3, P 5.26).
PCP Assessment of Patient Characteristics
PCPs were asked to assess two personal attributes of the
patient and five predicted patient behaviors. These assess-
ments did not differ by the race or sex of the patient (Table 3)
with the exception of estimates of the patient’s SES.
Notably, PCPs did not judge African-American patients as
any less likely to adhere to or benefit from treatment. With
regard to SES, both the WF and WM patients were rated as
Table 1. Characteristics of the Primary Care Physicians (PCPs) According to Race and Sex of Patient
Characteristic
White African-American
Significance Test P-valueFemale Male Female Male
PCPs, n 44 46 46 42
Age, mean 42.3 41.8 46.6 43.0 F 5 0.67(3,170) .57
Years since medical school graduation, mean 19.9 19.0 20.2 21.9 F 5 0.46(3,171) .71
Male, n (%) 32 (72.7) 32 (69.6) 32 (69.6) 29 (69.0) w2 5 0.18(3) .98
White, n (%) 30 (68.2) 33 (71.7) 36 (78.3) 27 (64.3) w2 5 2.27(3) .52
U.S. medical school location, n (%) 36 (81.8) 36 (78.3) 35 (76.1) 31 (73.8) w2 5 0.87(3) .83
Board certified, n (%) 42 (95.4) 41 (89.1) 44 (95.6) 35 (83.3) w2 5 5.50(3) .14
Urban practice location, n (%) 23 (52.3) 18 (39.1) 24 (52.2) 17 (40.5) w2 5 2.79(3) .43
Table 2. Follow-Up Choices Indicated by Primary Care Physicians (PCPs) by Vignette Viewed
Follow-Up Choice
White African-American
Female Male Female Male
PCPs, n 44 46 46 42
No further treatment, n (%) 0 (0.0) 0 (0.0) 0 (0.0) 1 (2.4)
Referral to psychiatrist, n (%) 1 (2.3) 3 (6.5) 3 (6.5) 1 (2.4)
Referral to a non-medical doctor mental health provider, n (%) 3 (6.8) 6 (13.0) 4 (8.7) 7 (16.7)
Referral to another specialist, n (%) 0 (0.0) 2 (4.4) 1 (2.2) 0 (0.0)
Follow-up, months, n (%)
1–3 15 (34.1) 16 (34.8) 19 (41.3) 12 (28.6)
4–6 3 (6.8) 6 (13.0) 2 (4.4) 2 (4.8)
46 22 (50.0) 13 (28.3) 17 (37.0) 19 (45.2)
F 5 17.82(18), P 5.47.
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being of significantly higher SES than the AF patient, and the
WM was rated as being of significantly higher SES than the
AM patient (Tukey’s post hoc comparison, Po.05). Given
the differences between vignettes found for SES, additional
analyses were performed using SES as a covariate. PCPs’
estimates of SES did not affect their choice of diagnosis.
Analyses Using PCP Characteristics
Associations between PCP characteristics and the diagnosis
of major depression, treatment, and management recom-
mendations are presented in Table 4. Of PCP characteris-
tics, location of medical school training, PCP race, and
board certification were associated with effects on diagnosis
and management recommendations. PCP sex, time since
graduation, and practice location did not influence diagno-
sis/recommendations.
Overall, 77.5% (n 5 138) of the total sample were U.S.
medical graduates (USMGs), whereas 22.5% (n 5 40) were
international medical graduates (IMGs). The overall racial
breakdown of the PCPs was as follows: white 5 70.8%
(n 5 126), Asian 5 18.5% (n 5 33), African-Ameri-
can 5 6.2% (n 5 11), Hispanic 5 3.4% (n 5 6), and oth-
er 5 1.1% (n 5 2). Ninety-one percent (n 5 162) of the
PCPs in the sample were board certified.
IMGs were significantly less likely than USMGs to di-
agnose depression, choose newer antidepressants as first-line




Female Male Female Male
Mean  Standard Deviation
Demeanor 34.0  11.4 32.6  9.8 37.1  13.2 36.4  11.8 1.40(3,174) .25
Socioeconomic statusw 48.5  16.6 50.9  13.1 38.3  16.7 41.0  15.9 6.59(3,174) o.001§
Individual assessment of predicted behaviorz
Likely to comply with treatment 50.3  20.1 52.7  20.5 48.5  20.6 51.7  19.8 0.36(3,174) .78
Likely to benefit from treatment 76.4  16.6 77.1  14.0 78.1  15.3 77.2  15.7 0.08(3,174) .97
Likely to form a treatment alliance 70.6  19.5 73.8  19.4 73.1  19.0 75.5  16.7 0.51(3,174) .67
Likely to understand recommendations 53.3  23.5 54.8  22.0 57.9  21.1 59.8  20.0 0.81(3,174) .49
Likely to have side effects 57.3  23.1 53.7  19.2 54.3  17.3 49.0  20.4 1.23(3,174) .30
0 5 hostile, 100 5 friendly.
w0 5 low, 100 5 high.
z0 5 very unlikely, 100 5 very likely.
§ Post hoc comparisons: white femaleAfrican-American female; white maleAfrican-American female and African-American male, Po.05.


















U.S. medical school graduate 6.10(1) .01 3.88(1) .049 8.51(1) o.001
Yes 122 (88.4) 121 (87.7) 63 (45.6)
No 29 (72.5) 30 (75.0) 8 (20.0)
White 13.89(1) o.001 3.57(1) .06 13.07(1) o.001
Yes 115 (91.3) 111 (88.1) 61 (48.4)
No 36 (69.2) 40 (76.9) 10 (19.2)
Male 0.22(1) .64 0.87(1) .35 0.51(1) .47
Yes 105 (84.0) 104 (83.2) 52 (41.6)
No 46 (86.8) 47 (88.7) 19 (35.8)
410 years since medical
school graduation
1.11(1) .29 2.43(1) .12 1.73(1) .19
Yes 120 (86.3) 121 (87.1) 59 (42.4)
No 31 (79.5) 30 (76.9) 12 (30.8)
Board certified 1.32(1) .25 6.81(1) .009 3.28(1) .07
Yes 139 (85.8) 141 (87.0) 68 (42.0)
No 12 (75.0) 10 (62.5) 3 (18.8)
Urban practice location 1.15(1) .28 0.43(1) .51 1.30(1) .26
Yes 67 (81.7) 68 (82.9) 29 (35.4)
No 84 (87.5) 83 (86.5) 42 (43.8)
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treatment, and recommend follow-up for longer than 6
months for the older patients. Additionally, in assessment of
patient characteristics, IMGs rated the AM patient as being
of significantly lower SES than did USMGs (t40 5 2.33,
P 5.03). Nonwhite PCPs were significantly less likely than
white PCPs to diagnose depression and recommend long-
term follow-up. There was also a trend for nonwhite PCPs
to be less likely to choose newer antidepressants as initial
treatment. Nonwhite PCPs were also significantly less likely
to think that the WM patient would benefit from treatment
(t44 5 2.14, P 5.04) or form a physician-patient alliance
(t44 5 3.04, Po.001) than did white PCPs. Board-cer-
tified PCPs were significantly more likely than non-board
certified PCPs to recommend treatment with newer antide-
pressants and more likely to recommend long-term follow-
up (trend-level). There were no differences in the diagnosis
or management of depression based upon patient race and
sex found in IMG, nonwhite, or non-board certified PCPs.
Post Hoc Analyses of PCP Characteristics
Separate logistic regression models were computed for each
PCP trait, with patient race and sex included as predictor
variables. The results for diagnosis indicated that only
medical school location (P 5.01) and PCP race (Po.001)
affected diagnosis; medical school location and PCP race
were found to be significantly correlated (coefficient of de-
termination (r2) 5 0.48, Po.001). IMGs were significantly
less likely to choose depression as a diagnosis than USMGs
(odds ratio (OR) 5 3.24, 95% CI 5 1.32–7.93). Nonwhite
PCPs were significantly less likely to choose depression as
a diagnosis than white PCPs (OR 5 4.83, 95% CI 5 2.02–
11.54). Physician sex, years since medical school gradua-
tion, board certification, and practice location did not pre-
dict diagnosis.
Medical school location (P 5.04) and board certifica-
tion (Po.001) significantly predicted prescription of newer
antidepressants; U.S. medical school location was found to
be significantly correlated with board certification
(r2 5 0.25, Po.001). IMGs were significantly less likely to
recommend newer antidepressants than USMGs (OR 5
2.50, 95% CI 5 1.036.07). Non-board certified PCPs
were also significantly less likely to choose newer antide-
pressants than board-certified PCPs (OR 5 5.16, 95%
CI 5 1.59–16.78). Physician sex, race, years since medical
school graduation, and practice location did not predict
prescription of newer antidepressants.
Given the findings that medical school location and
race were highly correlated and significantly associated
with correct diagnosis, these variables were further ana-
lyzed. For USMGs (n 5 138), racial identification was as
follows: 82.6% (n 5 114) white, 8.0% (n 5 11) African-
American, 5.8% (n 5 8) Asian, 2.9% (n 5 4) Hispanic,
and 0.7% (n 5 1) other. For IMGs (n 5 40), racial identi-
fication was 30.0% (n 5 12) white, 0% (n 5 0) African-
American, 62.5% (n 5 25) Asian, 5.0% (n 5 2) Hispanic,
and 2.5% (n 5 1) other. Of the 40 IMGs, 32.5% (n 5 13)
were from the Philippines, 17.5% (n 5 7) from India or
Pakistan, 12.5% (n 5 5) from Mexico or South America,
7.5% (n 5 3) from Canada, 7.5% (n 5 3) from the West
Indies/Caribbean, and 2.5% (n 5 1) from Syria, Vietnam,
Myanmar (formerly Burma), Thailand, and Japan. Ten per-
cent (n 5 4) were missing a medical school location. Of the
52 nonwhite physicians in the sample, 53.8% (n 5 28)
trained overseas.
Finally, in terms of PCP race, the percentage of PCP-
patient pairs that were racially matched (white patient/
white PCP or African-American patient/African-American
PCP) were assessed; 38.2% (n 5 68) of pairs were so
matched, but this racial matching did not correlate with
correct diagnosis or treatment.
DISCUSSION
These findings suggest that PCP bias based simply on pa-
tient skin color (as well as other characteristics associated
with race such as facial features and speech style) is not a
likely explanation for the lower rates of clinical depression
diagnoses in African Americans seen in primary care set-
tings. Although two case series of older African-American
patients (veterans in a long-term psychiatric facility23 and
patients referred to a community mental health center24)
suggested misdiagnosis, sample size and questions as to
whether the misdiagnosis was based upon patients’ race or
other factors limited these studies. The latter may include
nonracially based misdiagnoses that may have been more
prevalent before the DSM-III era. The current experimental
findings are concordant with a recent study that found that
neither race nor sex significantly affected rates of depres-
sion diagnoses or treatment in primary care settings.20
In clinical settings, race-associated disparities in de-
pression diagnosis and treatment patterns may result from
patient-level factors other than race as divined from a pa-
tient’s appearance. These factors may include different
symptom presentations of depression, lower usage of for-
mal healthcare settings for treatment of elderly African
Americans, and patient treatment preferences. Prior find-
ings that mixed-age African-American patients with de-
pression had higher ratings of hostility and irritability and a
greater frequency of somatic complaints suggest the first.33
Studies demonstrating different patterns of help-seeking
and healthcare utilization for depression of African Amer-
icans, including more reliance on informal support (friends,
ministers, etc.) for emotional problems, indicate the sec-
ond.34,35 A recent study finding that PCPs recognized de-
pression and recommended treatment for African-
American patients as often as for white patients but that
African-American patients were significantly less likely to
accept antidepressant medications supports the third.36
Differential symptom presentations, patterns of treatment-
seeking, and treatment preferences by race may have af-
fected prior studies finding lower rates of clinical depression
diagnoses and treatment in elderly African Americans. Sim-
ilarly, patient-level factors may also have affected prior
studies finding lower rates of depression in men, with men
seeking depression treatment at lower rates,37 being less
likely to recognize their depressive symptoms,38 and being
less likely to initiate discussions with providers about de-
pression than women.39 This study’s design standardized
patient presentations to isolate physician decision-making
to examine the question of whether a patient’s apparent
race or sex affected diagnostic and treatment decisions.
With standardized vignettes, PCPs did not express greater
uncertainty when making a diagnosis of major depression
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for the minority patients. Indeed, the mean level of certainty
of the depression diagnosis was significantly higher for the
African-American female patient than the white male pa-
tient. This finding may reflect PCPs acknowledging the
higher reported rates of depression in women and a possibly
heightened sensitivity to the concern of underdiagnosis of
depression in African-American patients given cultural
competency efforts.
PCPs’ estimates of SES appeared to be dissociated from
their assignments of diagnoses by vignette viewed. PCPs’
estimates of SES may have been based upon known pop-
ulation differences in income as opposed to racial bias. An-
other possibility is that PCPs’ estimates of SES may have
been racially based but that this bias was not associated
with different diagnostic impressions.
Although there was a lack of overall effects of patient
race and sex on PCP decision-making, it was found that
certain characteristics of the PCPs themselves affected de-
pression diagnosis and treatment recommendations. The
two factors that appeared to have the largest effect upon the
main study questions were PCP location of medical school
training and race. These factors were highly correlated with
each other; 70% of IMGs were nonwhite, and 54% of
nonwhite physicians were trained overseas.
Although there were no significant differences by pa-
tient race or sex between IMG and nonwhite PCPs for the
diagnosis and treatment of depression, several of the as-
sessments of patient characteristics pointed to possible in-
fluences of patient race and sex. IMG PCPs rated the
African-American male patient as being of lower SES than
did USMGs. Nonwhite PCPs also rated the white male pa-
tient as significantly less likely to benefit from treatment
and less able to form a physician-patient alliance than white
PCPs. These findings may reflect cultural differences within
the PCP/patient dyad.
Although physician influence on racial disparities is
often thought of as involving a white physician and a non-
white patient, it is also important to consider other possible
dyadic relationships (e.g., Asian physician/white patient).
Patient-provider race/ethnicity concordance has been found
to be positively associated with treatment outcomes,40 but
these analyses indicated that, in racially matched PCP/pa-
tient pairs, there was no correlation with correct diagnosis
and treatment of depression.
There is limited research examining the effects of hav-
ing received medical training outside the United States on
health disparities. One study found that before and after
PCP home care training seminars, IMG physicians were
significantly less likely to make home visits for older pa-
tients than U.S.-trained physicians.41 These authors spec-
ulated that IMG PCPs may not have had prior training with
or exposure to such services. Similarly, in this study, the
IMG PCPs may have had less familiarity with depressive
syndromes. A recent study42 that surveyed PCPs found that
providers’ previous treatment experiences, such as having
had older patients who responded to antidepressant treat-
ment, and their beliefs about the effectiveness of antide-
pressant treatments largely influenced the decision to treat
older patients with antidepressants. Many countries report
a lower prevalence of depression than does the United
States, potentially secondary to decreased reporting of
mental disorders, disorders that are often accompanied by
considerable stigma.43 These factors may affect the training
of IMG physicians and affect their recognition of depressive
syndromes while later practicing in the United States. The
findings of the present study are of practical concern be-
cause IMG physicians may work more frequently in the
public sector where they might treat patient populations
with higher proportions of elderly and minority patients.
The results may also point to the need for targeted educa-
tional initiatives for cultural/aging competency for IMG
PCPs providing much-needed care for minority elderly.
This study had several limitations. First, PCPs were in-
formed that the study purpose was to assess clinical deci-
sion-making regarding mental health issues in primary care.
Thus, the clinical encounter was simplified in that PCPs
already knew they would be making some type of mental
health diagnosis. Therefore, the rates of depression detec-
tion are likely artificially higher across the vignettes than
would be found in real-world settings in which PCPs might
ascribe symptoms to medical causes. Similarly, the vignettes
were 5 minutes long. Some PCPs commented that they
never would have asked so many questions related to a
mental health condition. Nevertheless, although these con-
cerns may have increased the overall detection of depression
diagnoses, they were present in all vignettes. Thus, it is un-
likely that they affected the main study questions of the
effects of race/sex. Additionally, the PCPs in this study were
drawn from a family physician sample. As a group, family
physicians may be more acculturated to mental health is-
sues than internists, and therefore their rates of depression
diagnosis and treatment may be higher than found in sam-
ples of other PCPs. The latter may affect the generalizability
of the results to all PCPs. Second, even though the vignettes
were meticulously standardized and piloted, it is possible
that subtle differences between actors’ appearances or non-
verbal communication might have affected the results. The
piloting process and focus work with psychiatrists did not
demonstrate such differences among the vignettes, but it is
not known whether the survey instrument correlates with
actual PCP decision-making. Several published studies sup-
port the use of case vignettes to assess clinical decision-
making by physicians,44–49 and video (rather than written)
vignettes may enhance the accuracy of such physician de-
cisions.49 Such techniques also permit a degree of control
unattainable in observational studies, allowing determina-
tion of the influence of nonmedical factors on physician
decision-making.50 However, PCP interviewing skills and
rapport building remain untested with the use of video pa-
tients, and these skills may be particularly important when
assessing the presence of depression in minority patients
and men. Third, PCPs were recruited at a national meeting,
which may have resulted in a nonrepresentative sample.
PCPs who attend such meetings and volunteered for the
study may be more attuned to the culturally sensitive di-
agnosis of major depression than those who do not.
These limitations notwithstanding, the finding of sim-
ilar rates of major depression diagnoses regardless of race or
sex in elderly people using a standardized patient video vi-
gnette represents a step toward understanding the role of
the physician in racial differences in late-life depression di-
agnosis and treatment in primary care settings. Although
earlier studies show clear differences between races for rates
of depression diagnoses, the present findings indicate that
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physician bias based simply on apparent patient race is not
a likely explanation.
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